2002 – 2008 – Siriraj Medical School, Mahidol University
2008 – 2013 – Department of Internal Medicine, Rajavithi Hospital
2013 – 2015 – Department of Cardiology, Internal Medicine Rajavithi Hospital
2019 – 2020 – Cardiology Intervention, Department of Cardiology, Internal Medicine Rajavithi Hospital
Languages: English and Thai
| ÉDUCATION | |
| |
| EXPÉRIENCES ET PRATIQUES DE TRAVAIL | |
| |
| AUTRES EXPÉRIENCES | |
| 2015-2017 | Instructrice étudiante infirmière à l'hôpital de Sai noi et à l'hôpital de Bangbuatong |
| 2015 | Membre du comité de pharmacie et de thérapeutique de l'hôpital de Bangbuatong |
| 2015 | Médecine d'urgence, organisée par l'hôpital Phramongkutklao |
| 2016 | Mise à jour en médecine interne, organisée par l'hôpital Siriraj |
| 2016 | Médecine ambulatoire, organisée par Chulalongkorn-Ramathibodi-Siriraj hôpital |
| 2016 | 5e atelier ECG, organisé par l'hôpital Chulalongkorn |
| RÉALISATIONS ACADÉMIQUES | |
| Co-auteur dans : Développement et validation d'une thromboembolie veineuse associée au cancer modèle de prédiction du risque clinique (CAT-CR) >> en attente de publication | |
Maladie diverticulaire de l'intestin (diverticulose)
Hydronéphrose (gonflement des reins)
Mauvais goût dans la bouche
Sang dans les urines (hématurie)
Abcès du foie
Troubles du métabolisme des graisses
Ostéomalacie (ramollissement des os)
Excès d'hormones
Maladies glomérulaires (néphrite, syndrome néphrotique)
Dr. Bum Seung Gyun
Prosthesis Specialist – Director
Dedicated prosthodontist with extensive clinical training and a strong academic foundation in prosthetic and restorative dentistry. Dr. Bum is a certified Conservative Specialist and holds memberships in several prestigious dental academies, reflecting his commitment to excellence and continued education in advanced dental care.
Internship & Residency in Prosthodontics
Wonkwang University Dental College Hospital
Conservative Specialist, certified by the Ministry of Health and Welfare
Full Member, Korean Academy of Prosthodontics
Full Member, Korean Academy of Advanced General Dentistry
Full Member, Korean Academy of Stomatognathic Function and Occlusion
Docteur en médecine, Cum Laude , Université de Navarre (1991)
Diplôme de médecine , Université de Navarre (1979-1985), avec mention
Spécialiste certifié en oncologie médicale , via le système espagnol MIR, Clínica Universidad de Navarra (1986-1989)
Bourse avancée en immunothérapie , Cleveland Clinic Foundation, États-Unis
Chef du service d'oncologie médicale (1993-2000) et directeur de l'Institut du cancer (2000-2002) , Hôpital général de Catalogne
Directeur du programme de transplantation de progéniteurs hématopoïétiques , Hôpital général de Catalogne (1993-2002), accrédité par le Département de la santé de Catalogne
Spécialiste principal en oncologie , Quirónsalud Torrevieja (depuis 2002)
Thérapie personnalisée contre le cancer utilisant des puces à ARN et la pharmacogénomique
Greffes de moelle osseuse autologues et chimiothérapie à haute dose
Traitement par interleukine-2 à haute dose par bolus intraveineux pour les tumeurs solides
Vaccins cellulaires antitumoraux personnalisés
Perfusion hyperthermique isolée des membres avec TNF et melphalan
Chimiothérapie intra-artérielle et peropératoire (HIPEC) pour les cancers avancés
Auteur de plus de 120 articles scientifiques et présentations de conférences
Contributeur actif au développement de nouvelles immunothérapies contre le cancer et de stratégies de personnalisation des médicaments
AACR – Association américaine pour la recherche sur le cancer
ASCO – Société américaine d'oncologie clinique
ASH – Société américaine d'hématologie
Dr. Polina Stepensky is a top specialist in pediatric bone marrow transplantation. She has over 20 years of experience and has performed more than 3,500 bone marrow transplants. Dr. Stepensky focuses on treating children with rare blood cancers.
She is highly respected by colleagues and patients. In 2018, Forbes named her one of the best doctors. Families trust her for advanced care in complex blood diseases.
Dr. Irina Zaidman is a specialist in Pediatric Hematology and Oncology at Hadassah Medical Center. She has advanced training in pediatric residency, hemato-oncology, and bone marrow transplantation (BMT). Dr. Zaidman completed fellowships at Rambam Medical Center and the Hospital for Sick Children in Toronto.
She serves on the board of the Israeli Pediatric Hemato-Oncology Society. She is also an active member of European and American BMT societies. Dr. Zaidman has published several articles on pediatric BMT. She is known for her work in teaching and clinical research.
Professor Dina Ben-Yehuda is a leading oncohematologist in Israel. She directs the Hematology Department at Hadassah Medical Center. She founded the laboratory for molecular diagnostics of blood diseases. She is known for her research in malignant blood diseases, bone marrow transplantation, gene therapy, and immunology.
Prof. Ben-Yehuda completed her postgraduate training at Memorial Sloan-Kettering Cancer Center. She has led Hadassah’s hematology department since 2000. In 2017, she became the first woman to serve as Dean of the Hadassah School of Medicine. She has received the Danielle Sonnenfeld Foundation’s Healing with the Heart Award. She is also a member of several national and international hematology societies.
Oncohématologue
Spécialiste en hématologie. Spécialisé dans le traitement des lymphomes.
Chef du service d'hématologie pédiatrique.
Spécialiste en radiothérapie, Oncologue
Professeur, spécialiste en hématologie et transplantation
Dr. Gal Goldstein is a leading specialist in Pediatric Oncology and Hemato-Oncology at Hadassah Medical Center. He is the Head of the Pediatric Oncology and Hemato-Oncology Department at Hadassah Hospital Ein Kerem.
Dr. Goldstein has over 20 years of experience. He focuses on retinoblastoma, precision medicine, and haploidentical bone marrow transplantation. He graduated from Tel Aviv University. In 2019-2020, Forbes named him one of the best doctors in Israel.
Dr. Goldstein is a member of The Israel Society of Pediatric Hematology and Oncology, The Israeli Cancer Association, and The International Society of Pediatric Oncology. He is dedicated to advancing pediatric cancer care.
Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.
He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.
He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.